Brad Davis is a principal at Norstella with a depth of experience deriving actionable insights from real-world data (RWD). Brad has been in the pharmaceutical industry for 20+ years spanning clinical development, management consulting, and communications. This unique blend of clinical and commercial expertise including clinical trial strategy and design, patient recruitment, portfolio optimization, and commercial launch strategy allows for an innovative approach to problem solving. He has significant experience across therapeutic areas, particularly psychiatry, neurology, oncology, immunology, and rare diseases.